[Keratoconus treatment by corneal cross-linking (CLX)]

Revue Medicale Suisse
|July 10, 2014
PubMed
Summary

Corneal collagen cross-linking (CXL) effectively halts keratoconus progression in over 95% of cases. Early detection and timely CXL treatment are crucial to prevent irreversible vision loss from this progressive corneal disease.